Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1986 Aug;322(6079):547-9.
doi: 10.1038/322547a0.

Tumour necrosis factor alpha stimulates resorption and inhibits synthesis of proteoglycan in cartilage

Tumour necrosis factor alpha stimulates resorption and inhibits synthesis of proteoglycan in cartilage

J Saklatvala. Nature. 1986 Aug.

Abstract

During inflammatory reactions, activated leukocytes are thought to produce a variety of small proteins (cytokines) that influence the behaviour of other cells (including other leukocytes). Of these substances, which include the interleukins, interferons and tumour necrosis factors (TNFs), interleukin-1 (IL-1) has been considered potentially a most important inflammatory mediator because of its wide range of effects. In vivo it is pyrogenic and promotes the acute phase response; in vitro it activates lymphocytes and stimulates resorption of cartilage and bone. Cartilage resorption is a major feature of inflammatory diseases such as rheumatoid arthritis, and IL-1 is the only cytokine hitherto known to promote it. TNFs are characterized by their effects on tumours and cytotoxicity to transformed cells, but share some actions with IL-1. I report here that recombinant human TNF alpha stimulates resorption and inhibits synthesis of proteoglycan in explants of cartilage. Its action is similar to and additive with IL-1, and it is a second macrophage-derived cytokine whose production in rheumatoid arthritis, or inflammation generally, could contribute to tissue destruction.

PubMed Disclaimer

References

    1. Dinarello CA. Rev. infect. Dis. 1984;6:51–95. doi: 10.1093/clinids/6.1.51. - DOI - PubMed
    1. Durum SK, Schmidt JA, Oppenheim JJ. A. Rev. Immun. 1985;3:263–287. doi: 10.1146/annurev.iy.03.040185.001403. - DOI - PubMed
    1. Mizel SB. Immun. Rev. 1982;63:51–72. doi: 10.1111/j.1600-065X.1982.tb00411.x. - DOI - PubMed
    1. Saklatvala J, Pilsworth LMC, Sarsfield SJ, Gavrilovic J, Heath JK. Biochem. J. 1984;224:461–466. doi: 10.1042/bj2240461. - DOI - PMC - PubMed
    1. Gowen M, Wood DD, Ihrie EJ, McGuire MKB, Russell RGG. Nature. 1983;306:378–380. doi: 10.1038/306378a0. - DOI - PubMed

Publication types